Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

BACKGROUND: Patients with rheumatoid arthritis (RA) have an increased risk of certain solid cancers, in particular lung cancer, compared to the general population. Treatment with tumour necrosis factor (TNF) inhibitors (TNFi) may further enhance this risk. OBJECTIVES: To compare the risk of solid ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercer, Louise K, Lunt, Mark, Low, Audrey L S, Dixon, William G, Watson, Kath D, Symmons, Deborah P M, Hyrich, Kimme L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431340/
https://www.ncbi.nlm.nih.gov/pubmed/24685910
http://dx.doi.org/10.1136/annrheumdis-2013-204851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431340/
https://www.ncbi.nlm.nih.gov/pubmed/24685910
http://dx.doi.org/10.1136/annrheumdis-2013-204851

Ejemplares similares